Assessment of CCM in HF With Higher Ejection Fraction
NCT: NCT05064709 · RECRUITING
NCT IDNCT05064709
StatusRECRUITING
Start Date2022-02-03
Completion2029-02-01
Brief Summary
The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure with LVEF ≥40% and ≤70%.
Frequently Asked Questions
What is Assessment of CCM in HF With Higher Ejection Fraction?
Assessment of CCM in HF With Higher Ejection Fraction is a clinical trial registered under NCT05064709. Current status: RECRUITING.
What is the status of NCT05064709?
The current status of NCT05064709 (Assessment of CCM in HF With Higher Ejection Fraction) is: RECRUITING.
When did Assessment of CCM in HF With Higher Ejection Fraction start?
Assessment of CCM in HF With Higher Ejection Fraction started on 2022-02-03.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.